Hematology Department

The clinical characteristics of the Beijing Morning Hospital, affiliated with the Capital Medical University, are distinctive in terms of blood therapy, focusing on multiple myeloma, leukemia, MDS and lymphoma. Since the 1970s, it has conducted research primarily on multiple myeloma, gained access to a number of national and provincial scientific research topics, led the development of industry standards and consensus, actively promoted the standardized diagnosis of domestic myeloma, diagnosing more than 3,000 patients with osteomyelitis annually nationwide and abroad, including a large number of patients with serious and suspected relapses. It is a nationally recognized osteochondrosis clinic, has a leading position in the field of osteochondrosis and has long-standing friendly partnerships with countries such as Europe and America. The distinctive features of the Department of Leukemia and Lymphoma are clear, the head of the department is a professor who is an internationally renowned expert on leukaemia, has pioneered internationally a new model for family oral therapy of acute early cell leukemia and a new program to induce DAV in acute myelogenous leukemia, currently focusing on adopting the latest international technological means, leading the way in oral medicine and immunotherapy. While improving survival rates, patients also improve their quality of life.